FR2943345B1 - Analogues de la temporine-sha et leurs utilisations - Google Patents

Analogues de la temporine-sha et leurs utilisations

Info

Publication number
FR2943345B1
FR2943345B1 FR0951768A FR0951768A FR2943345B1 FR 2943345 B1 FR2943345 B1 FR 2943345B1 FR 0951768 A FR0951768 A FR 0951768A FR 0951768 A FR0951768 A FR 0951768A FR 2943345 B1 FR2943345 B1 FR 2943345B1
Authority
FR
France
Prior art keywords
temporin
sha
analogues
sha analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0951768A
Other languages
English (en)
Other versions
FR2943345A1 (fr
Inventor
Ali Ladram
Denis Sereno
Feten Abbassi
Bruno Oury
Mohamed Amiche
Pierre Nicolas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Pierre et Marie Curie Paris 6
Institut de Recherche pour le Developpement IRD
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Pierre et Marie Curie Paris 6
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0951768A priority Critical patent/FR2943345B1/fr
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Pierre et Marie Curie Paris 6, Institut de Recherche pour le Developpement IRD filed Critical Centre National de la Recherche Scientifique CNRS
Priority to JP2012500299A priority patent/JP5713211B2/ja
Priority to US13/257,018 priority patent/US9522942B2/en
Priority to PCT/FR2010/050487 priority patent/WO2010106293A1/fr
Priority to CA2755472A priority patent/CA2755472C/fr
Priority to EP10716554A priority patent/EP2408806A1/fr
Priority to BRPI1009585A priority patent/BRPI1009585A2/pt
Publication of FR2943345A1 publication Critical patent/FR2943345A1/fr
Application granted granted Critical
Publication of FR2943345B1 publication Critical patent/FR2943345B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/463—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from amphibians
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8282—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for fungal resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0951768A 2009-03-19 2009-03-19 Analogues de la temporine-sha et leurs utilisations Expired - Fee Related FR2943345B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0951768A FR2943345B1 (fr) 2009-03-19 2009-03-19 Analogues de la temporine-sha et leurs utilisations
US13/257,018 US9522942B2 (en) 2009-03-19 2010-03-18 Analogs of temporin-SHa and uses thereof
PCT/FR2010/050487 WO2010106293A1 (fr) 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations
CA2755472A CA2755472C (fr) 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations
JP2012500299A JP5713211B2 (ja) 2009-03-19 2010-03-18 テンポリン−ＳＨａ類縁体及びその使用
EP10716554A EP2408806A1 (fr) 2009-03-19 2010-03-18 Analogues de la temporine-sha et leurs utilisations
BRPI1009585A BRPI1009585A2 (pt) 2009-03-19 2010-03-18 peptídeo, ácido nucleico, cassete de expressão, vetor de expressão, célula hospedeira, composição farmacêutica, utilização de um peptídeo, aparelhagem médica ou implante, e, planta transgênica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0951768A FR2943345B1 (fr) 2009-03-19 2009-03-19 Analogues de la temporine-sha et leurs utilisations

Publications (2)

Publication Number Publication Date
FR2943345A1 FR2943345A1 (fr) 2010-09-24
FR2943345B1 true FR2943345B1 (fr) 2011-05-27

Family

ID=41066385

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0951768A Expired - Fee Related FR2943345B1 (fr) 2009-03-19 2009-03-19 Analogues de la temporine-sha et leurs utilisations

Country Status (7)

Country Link
US (1) US9522942B2 (fr)
EP (1) EP2408806A1 (fr)
JP (1) JP5713211B2 (fr)
BR (1) BRPI1009585A2 (fr)
CA (1) CA2755472C (fr)
FR (1) FR2943345B1 (fr)
WO (1) WO2010106293A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2853538A1 (fr) 2013-09-27 2015-04-01 Université Pierre et Marie Curie (Paris 6) Analogues de temporin-Sha et leurs utilisations
JP6731348B2 (ja) * 2013-12-12 2020-07-29 アカデミス ズィーケンハイス レイデン ハー．オー．デー．エン． エルユーエムセー 抗微生物ペプチドおよびその使用
CN106117333A (zh) * 2016-07-06 2016-11-16 贵州师范大学 合江棘蛙皮肤抗菌肽及其编码序列的基因及原核表达
US10550155B2 (en) * 2018-03-27 2020-02-04 Farzana Shaheen Anticancer peptides
WO2022259007A1 (fr) 2021-06-11 2022-12-15 Sorbonne Universite Peptides antimicrobiens courts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1194092A (en) * 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US5916872A (en) * 1996-07-24 1999-06-29 Intrabiotics Pharmaceuticals, Inc. Cyclic peptides having broad spectrum antimicrobial activity

Also Published As

Publication number Publication date
US9522942B2 (en) 2016-12-20
EP2408806A1 (fr) 2012-01-25
JP2012520665A (ja) 2012-09-10
FR2943345A1 (fr) 2010-09-24
WO2010106293A1 (fr) 2010-09-23
JP5713211B2 (ja) 2015-05-07
BRPI1009585A2 (pt) 2016-03-08
US20120005790A1 (en) 2012-01-05
CA2755472A1 (fr) 2010-09-23
CA2755472C (fr) 2017-11-21

Similar Documents

Publication Publication Date Title
FR17C1059I2 (fr) Composes de pyrrolopyrimidine et leurs utilisations
SMT201300040B (it) Analoghi piridonici e piridazonici come modulatoridi gpr119
DK2462134T3 (da) N1-sulfonyl-5-fluorpyrimidinonderivater
DK2398483T3 (da) Oxyntomodulinanaloge
FR2963889B1 (fr) Formulations a base de nalbuphine et leurs utilisations
FI20106131A0 (fi) Insertteri
FR2953129B1 (fr) Orthese dynamique
FR2942476B1 (fr) Composes de type pyridocarbazole et leurs applications
DOP2011000348A (es) Construcciones casb7439
FR2964937B1 (fr) Triporteur et direction de triporteur
FR2943345B1 (fr) Analogues de la temporine-sha et leurs utilisations
ES1069369Y (es) Fija sombrillas
DK2310037T3 (da) Conglutin-gamma as-medikament og -kosttilskudpatentkrav
ES1070530Y (es) Expositor dinamico
FR2953126B1 (fr) Orthese dynamique
FR2955741B1 (fr) Composition herbicide et utilisations
FI20096360A0 (fi) Bioliima ja puulevy
ES1071635Y (es) Anclaje recuperable
TH129804B (th) องค์ประกอบที่ใช้ภายนอก
ES1071202Y (es) Forjado unidireccional
TH103412B (th) แผงแบบแขวนที่มีวงจรและวิธีการผลิตแผงดังกล่าว
FI20090281A0 (fi) Rakennuselementti
TH114434B (th) คาร์บอไฮเดรต
TH101297B (th) โครงสร้างป้องกันหินหล่นและวิธีดำเนินการดังกล่าว
UA20207S (uk) Вежо-щоглова споруда

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

ST Notification of lapse

Effective date: 20191106